Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;102:933-941
Published online before print February 28, 2008, doi: 10.1161/CIRCRESAHA.108.171082
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
102/8/933    most recent
CIRCRESAHA.108.171082v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chang, P.-Y.
Right arrow Articles by Lee, Y.-T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, P.-Y.
Right arrow Articles by Lee, Y.-T.
Related Collections
Right arrow Risk Factors
Right arrow Cell signalling/signal transduction
Right arrow Gene regulation
Right arrow Growth factors/cytokines
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Mechanism of atherosclerosis/growth factors
Right arrowRelated Article
(Circulation Research. 2008;102:933.)
© 2008 American Heart Association, Inc.


Molecular Medicine

Homocysteine Inhibits Arterial Endothelial Cell Growth Through Transcriptional Downregulation of Fibroblast Growth Factor-2 Involving G Protein and DNA Methylation

Po-Yuan Chang*, Shao-Chun Lu*, Chii-Ming Lee, Yi-Jie Chen, Tracey A. Dugan, Wen-Huei Huang, Shwu-Fen Chang, Warren S.L. Liao, Chu-Huang Chen, Yuan-Teh Lee

From the Departments of Internal Medicine (P.-Y.C., C.-M.L., Y.-T.L.) and Biochemistry and Molecular Biology (S.-C.L., Y.-J.C., W.-H.H.), National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei; Graduate Institute of Cell and Molecular Biology (S.-F.C.), Taipei Medical University, Taipei; the Department of Biochemistry and Molecular Biology (W.S.L.L.), Program in Genes and Development, University of Texas M.D. Anderson Cancer Center, Houston; and the Department of Medicine (T.A.D., C.-H.C.), Baylor College of Medicine, Houston, Tex.

Correspondence to Yuan-Teh Lee, MD, PhD, No. 7, Chung-Shan South Rd, Taipei 100, Taiwan. E-mail ytlee{at}ha.mc.ntu.edu.tw

Homocysteine (Hcy) contributes to atherogenesis and angiostasis by altering the phenotype of arterial endothelial cells (ECs). The present study was aimed at elucidating potential mechanisms by which Hcy can slow EC proliferation and induce EC apoptosis, thereby disrupting endothelial integrity. Given the strong mitogenic and antiapoptotic properties of fibroblast growth factor (FGF)2, we examined whether Hcy can modulate its expression. In cultured human coronary and bovine aortic ECs, Hcy exerted time- and concentration-dependent (0 to 500 µmol/L) reduction of the mRNA and protein levels of FGF2, whereas vascular endothelial growth factor expression was not affected until Hcy reached a proapoptotic 500 µmol/L. By testing a panel of signal transduction inhibitors, we found that the Hcy-induced downregulation of FGF2 was specifically attenuated by pertussis toxin, an inhibitor of Gi protein signaling. Hcy induced cell cycle arrest at the G1/S transition and increased TUNEL-positive apoptotic cells in a graded manner. These effects were effectively counteracted by exogenous FGF2. Reporter gene assays showed that Hcy downregulated FGF2 by transcriptional repression of the gene promoter encompassed in a CpG dinucleotide-rich island. This region was heavily methylated at the cytosine residues by Hcy despite decreased methylation potential (S-adenosylmethionine to S-adenosylhomocysteine ratio). Normal levels of FGF2 transcription were restored to ECs simultaneously exposed to Hcy and 5-aza-deoxycytidine. We conclude that homocysteine disrupts the growth and survival of ECs through a G protein–mediated pathway associated with altered promoter DNA methylation and the transcriptional repression of FGF2.


Key Words: homocysteine • endothelial cells • growth factors • transcriptional regulation • DNA methylation


Related Article:

Hyperhomocysteinemia and Occlusive Vascular Disease: An Emergent Role for Fibroblast Growth Factor 2
Miguel Ángel Medina
Circ. Res. 2008 102: 869-870. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
HypertensionHome page
A. Zulli, E. Lau, B. P.P. Wijaya, X. Jin, K. Sutarga, G. D. Schwartz, J. Learmont, P. J. Wookey, A. Zinellu, C. Carru, et al.
High Dietary Taurine Reduces Apoptosis and Atherosclerosis in the Left Main Coronary Artery: Association With Reduced CCAAT/Enhancer Binding Protein Homologous Protein and Total Plasma Homocysteine but not Lipidemia
Hypertension, June 1, 2009; 53(6): 1017 - 1022.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. A. Medina
Hyperhomocysteinemia and Occlusive Vascular Disease: An Emergent Role for Fibroblast Growth Factor 2
Circ. Res., April 25, 2008; 102(8): 869 - 870.
[Full Text] [PDF]